Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 9,12 M
EBIT 2016 4,05 M
Net income 2016 4,05 M
Debt 2016 -
Yield 2016 -
Sales 2017 10,2 M
EBIT 2017 6,14 M
Net income 2017 3,39 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 8,14
P/E ratio 2017 8,82
Capi. / Sales 2016 3,69x
Capi. / Sales 2017 3,31x
Capitalization 33,7 M
More Financials
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
05/10 | 10:00pmShareholder meeting
More about the company
Latest news on INTELGENX TECHNOLOGIES COR
05/06 INTELGENX TECHNOLOGIES CORP. : Other Events (form 8-K)
05/06 INTELGENX TECHNOLOGIES : to Report First Quarter 2016 Financial Results on May 1..
05/06 INTELGENX TECHNOLOGIES : to Report First Quarter 2016 Financial Results on May 1..
03/30 INTELGENX TECHNOLOGIES : And redhill biopharma announce rizaport commercializati..
03/29 INTELGENX TECHNOLOGIES : Other Events (form 8-K)
03/29 INTELGENX TECHNOLOGIES : and RedHill Biopharma Announce RIZAPORT(TM) Commerciali..
03/29 INTELGENX TECHNOLOGIES : and RedHill Biopharma Announce RIZAPORT(TM) Commerciali..
03/28 INTELGENX TECHNOLOGIES : Announces development and commercialization term sheet ..
More news
Sector news : Generic Pharmaceuticals
05/06DJSalesforce Adds 800 Jobs in Indiana After Civil Rights Win
05/06DJSalesforce Adds 800 Jobs in Indiana After Civil Rights Win
05/06 Drug firms face industrywide probe by price regulator
More sector news : Generic Pharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions